Drug Search Results
More Filters [+]

CPP-115

Alternative Names: cpp-115
Latest Update: 2023-08-22
Latest Update Note: News Article

Product Description

Mechanisms of Action: ABAT Deactivator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Catalyst
Company Location: SOUTH SAN FRANCISCO CA 94080
Company CEO: Nassim Usman
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CPP-115

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Cocaine-Related Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CPP-115-0001

P1

Completed

Cocaine-Related Disorders

2012-06-01

Recent News Events